» Articles » PMID: 7944634

Increased Endothelin-1 Production in Fibroblasts Derived from Patients with Systemic Sclerosis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 1994 Aug 1
PMID 7944634
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine whether fibroblasts from patients with systemic sclerosis (SSc) produce excessive amounts of endothelin-1 (ET-1), which is recognised as having vasoconstrictive properties and as having a potent mitogenic effect on fibroblasts.

Methods: Dermal fibroblasts were removed from 11 patients with SSc and from five normal controls (NC). The assay of ET-1 protein was measured by an ELISA that used two anti-ET-1 antibodies. The gene expression of prepro ET-1 mRNA was evaluated by a reverse-transcriptase polymerase chain reaction (RT-PCR) method.

Results: Levels of ET-1 protein were significantly higher in SSc fibroblast cultures than in those of normal fibroblasts (p < 0.01). The expression of prepro ET-1 mRNA was also higher in SSc fibroblasts than in normal fibroblasts. The addition of interleukin-1 beta (IL-1 beta) increased the production of ET-1 by fibroblasts.

Conclusion: The findings indicate that the overproduction of ET-1 is a novel abnormal function in SSc fibroblasts, and that ET-1 induced by fibroblasts may play a role in the fibrosis and Raynaud's phenomenon of SSc.

Citing Articles

Animal Models of Systemic Sclerosis: Using Nailfold Capillaroscopy as a Potential Tool to Evaluate Microcirculation and Microangiopathy: A Narrative Review.

Mandujano A, Golubov M Life (Basel). 2022; 12(5).

PMID: 35629370 PMC: 9147447. DOI: 10.3390/life12050703.


Role of Alarmins in the Pathogenesis of Systemic Sclerosis.

Giovannetti A, Straface E, Rosato E, Casciaro M, Pioggia G, Gangemi S Int J Mol Sci. 2020; 21(14).

PMID: 32679721 PMC: 7404317. DOI: 10.3390/ijms21144985.


Novel Neuropathic Pain Mechanisms Associated With Allergic Inflammation.

Fujii T, Yamasaki R, Kira J Front Neurol. 2020; 10:1337.

PMID: 31920952 PMC: 6928142. DOI: 10.3389/fneur.2019.01337.


Animal models of systemic sclerosis: their utility and limitations.

Artlett C Open Access Rheumatol. 2014; 6:65-81.

PMID: 27790036 PMC: 5045111. DOI: 10.2147/OARRR.S50009.


Current perspectives on the immunopathogenesis of systemic sclerosis.

Fuschiotti P Immunotargets Ther. 2016; 5:21-35.

PMID: 27529059 PMC: 4970639. DOI: 10.2147/ITT.S82037.


References
1.
Feghali C, Bost K, Boulware D, Levy L . Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol. 1992; 19(8):1207-11. View

2.
Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S . Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992; 50(4):247-55. DOI: 10.1016/0024-3205(92)90331-i. View

3.
Kawaguchi Y, Harigai M, Kitani A, Suzuki K, Kawakami M, Ishizuka T . Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis. J Rheumatol. 1992; 19(11):1710-5. View

4.
Wang D, Tang C, Wung B, Chen H, Hung M, Wang J . Cyclical strain increases endothelin-1 secretion and gene expression in human endothelial cells. Biochem Biophys Res Commun. 1993; 195(2):1050-6. DOI: 10.1006/bbrc.1993.2150. View

5.
Horio T, Kohno M, Yasunari K, Murakawa K, Yokokawa K, Ikeda M . Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells. Atherosclerosis. 1993; 101(2):185-90. DOI: 10.1016/0021-9150(93)90115-b. View